339 related articles for article (PubMed ID: 9164182)
41. [Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma].
Wasser K; Moehler T; Nosas-Garcia S; Rehm C; Bartl R; Goldschmidt H; Düber C; Kauczor HU; Delorme S
Rofo; 2005 Aug; 177(8):1116-22. PubMed ID: 16021544
[TBL] [Abstract][Full Text] [Related]
42. How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer?
Perrin-Resche I; Bizais Y; Buhe T; Fiche M
Eur J Nucl Med; 1993 May; 20(5):420-5. PubMed ID: 8390936
[TBL] [Abstract][Full Text] [Related]
43. Prognostic importance of magnetic resonance imaging in bone marrow involvement of Hodgkin disease.
Varan A; Cila A; Büyükpamukçu M
Med Pediatr Oncol; 1999 Apr; 32(4):267-71. PubMed ID: 10102020
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy.
Staples WG; Gétaz EP
S Afr Med J; 1977 Jul; 52(2):60-3. PubMed ID: 578338
[TBL] [Abstract][Full Text] [Related]
45. [Bone marrow involvement in Hodgkin's disease: MR tomography and chemical-shift imaging].
Kauczor HU; Bentz M; Bischoff H; Gückel F; Döhner H; Brix G; van Kaick G
Rofo; 1993 Dec; 159(6):555-61. PubMed ID: 8298116
[TBL] [Abstract][Full Text] [Related]
46. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging.
Shields AF; Porter BA; Churchley S; Olson DO; Appelbaum FR; Thomas ED
J Clin Oncol; 1987 Feb; 5(2):225-30. PubMed ID: 3806167
[TBL] [Abstract][Full Text] [Related]
47. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
48. Bone marrow in malignant lymphoma.
McKenna RW; Hernandez JA
Hematol Oncol Clin North Am; 1988 Dec; 2(4):617-35. PubMed ID: 3065322
[TBL] [Abstract][Full Text] [Related]
49. [Value of Beckenkamm histobiopsy in the diagnosis of malignant lymphoma infiltrates in bone marrow].
Günther C; Helbig W; Püschel W; Hofmann FA
Z Gesamte Inn Med; 1982 Jul; 37(14):445-53. PubMed ID: 7136088
[TBL] [Abstract][Full Text] [Related]
50. [Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].
Liu EB; Chen HS
Ai Zheng; 2005 Nov; 24(11):1416-20. PubMed ID: 16552975
[TBL] [Abstract][Full Text] [Related]
51. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
Hoh CK; Glaspy J; Rosen P; Dahlbom M; Lee SJ; Kunkel L; Hawkin RA; Maddahi J; Phelps ME
J Nucl Med; 1997 Mar; 38(3):343-8. PubMed ID: 9074514
[TBL] [Abstract][Full Text] [Related]
52. [Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow].
Reske SN; Karstens JH; Henrich MM; Sohn M; Glöckner W; Jakse G; Büll U
Nuklearmedizin; 1993 Jun; 32(3):111-9. PubMed ID: 8327329
[TBL] [Abstract][Full Text] [Related]
53. Bone marrow biopsy in staging of malignant lymphomas.
Singh T; Harjinder ; Gaiha M
J Assoc Physicians India; 1989 Aug; 37(8):513-4. PubMed ID: 2621187
[TBL] [Abstract][Full Text] [Related]
54. CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies.
Agid R; Sklair-Levy M; Bloom AI; Lieberman S; Polliack A; Ben-Yehuda D; Sherman Y; Libson E
Clin Radiol; 2003 Feb; 58(2):143-7. PubMed ID: 12623044
[TBL] [Abstract][Full Text] [Related]
55. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders.
Sah SP; Matutes E; Wotherspoon AC; Morilla R; Catovsky D
J Clin Pathol; 2003 Feb; 56(2):129-32. PubMed ID: 12560392
[TBL] [Abstract][Full Text] [Related]
56. [Preliminary evaluation of PET-CT and DWI for the detection of lymphoma bone marrow infiltration].
Wu Y; Su LP; Yang XT; Zhang JX; Zhao M; Zhang Z; Guan T; Liu XL; Zheng YP; Han WE
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):853-860. PubMed ID: 27998446
[No Abstract] [Full Text] [Related]
57. Magnetic resonance imaging in the initial staging of Hodgkin's disease and non-Hodgkin lymphoma.
Tesoro-Tess JD; Balzarini L; Ceglia E; Petrillo R; Santoro A; Musumeci R
Eur J Radiol; 1991; 12(2):81-90. PubMed ID: 2037005
[TBL] [Abstract][Full Text] [Related]
58. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567
[TBL] [Abstract][Full Text] [Related]
59. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.
Agrawal K; Mittal BR; Bansal D; Varma N; Srinivasan R; Trehan A; Manohar K; Kashyap R; Bhattacharya A; Marwaha RK
Ann Nucl Med; 2013 Feb; 27(2):146-51. PubMed ID: 23143537
[TBL] [Abstract][Full Text] [Related]
60. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
